David Yudovich

David Yudovich has a diverse work experience spanning various fields and roles. David co-founded and served as the CEO of TIGERQ starting in 2018. Prior to that, they pursued PhD studies and worked as a Project Assistant at Lund University from 2014 to 2021. David also worked as a Research Assistant at Brigham and Women's Hospital from 2012 to 2014. In 2012, they were a Pratt Undergrad Research Fellow and an NAE Grand Challenge Scholar at Pratt School of Engineering, Duke University, with a focus on genetic therapy and personalized medicine. David also served as a Residential Assistant and conducted research in biochemistry and molecular cloning techniques. In 2010, they held the position of Chief Strategic Officer at Duke Venture Capital Club, where they contributed to strategic planning and organizational development. David has also volunteered at Duke University Medical Center as an Emergency Department Volunteer and at Rambam Medical Center as a Security Officer. Additionally, they served in the Israel Defense Forces as an Armored Core Officer and volunteered with the Israel Red Cross. David'searliest work experience was as an Audio Visual Dept/Soundman at Leo Baeck Education Center.

David Yudovich's education history begins in 1996 when they attended Leo Baeck Education Center for their high school education. During this time, they concentrated on chemistry and biology. In 2002, David enrolled at Ben-Gurion University of the Negev for an unspecified course of study. David then proceeded to complete IDF and Security Officer Training Courses within the same year. From 2008 to 2012, David pursued a degree in Biomedical Engineering at Duke University, focusing on chemistry and biology. Finally, they attended Lund University from 2014 to 2023, where they obtained a Doctor of Philosophy (PhD) in Biomedicine.